Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
Main Authors: | Jan Christoph Banck, Niklas Mueller, Sibylle Christiane Mellinghoff, Martin Thelen, Alessia Fraccaroli, Viktoria Blumenberg, Philipp Koehler, Wolfgang Gerhard Kunz, Martina Rudelius, Florian Schrötzlmair, Marion Subklewe, Hans Anton Schlößer, Johanna Tischer, Oliver Andreas Cornely, Lars Hartwin Lindner, Michael von Bergwelt-Baildon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000530 |
Similar Items
-
Invasive Aspergillosis in Patients Treated With Ibrutinib
by: Moritz Fürstenau, et al.
Published: (2020-04-01) -
Advances against Aspergillosis and Mucormycosis
by: David A. Stevens
Published: (2020-12-01) -
Dual Disseminated Aspergillosis and Mucormycosis Diagnosed at Autopsy: A Report of Two Cases of Coinfection and a Review of the Literature
by: Jason Murray, et al.
Published: (2023-03-01) -
COVID-19 coinfection with Mucormycosis
by: Mohammad Hajijafari, et al.
Published: (2023-07-01) -
A fatal case report of invasive pulmonary aspergillosis and mucormycosis coinfection in an immunocompetent patient with coronavirus disease 2019 in Korea
by: Jin Hyoung Kim, et al.
Published: (2023-08-01)